Studies provide a differentiated view of biotech upsurge in developing countries
15-Jan-2007
Biotech is booming in many (but not all) developing countries, a trend which is reflected by increases not only in research funding, but also in patenting and publishing. In its current edition, the Bienentanz Buzz Letter points to some recent studies which, on the basis of extensive facts, figures and interviews, explain the differences in approach and subsequent success levels between some of the higher-profile countries such as Brazil, China, Cuba, Egypt, India, South Africa and South Korea.
Other news from the department business & finance
